Check out this article in @FierceBiotech by @amirahalidrus featuring Intellia President and CEO, John Leonard, M.D., discussing his path to Intellia, the company’s full-spectrum approach to #genomeediting using #CRISPR/Cas9 and what’s to come in 2021. https://t.co/DGCVmIh3AY